Wuxi Biologics Stock Gross Profit
WXIBF Stock | USD 1.63 0.05 2.98% |
WuXi Biologics fundamentals help investors to digest information that contributes to WuXi Biologics' financial success or failures. It also enables traders to predict the movement of WuXi Pink Sheet. The fundamental analysis module provides a way to measure WuXi Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WuXi Biologics pink sheet.
WuXi |
WuXi Biologics Company Gross Profit Analysis
WuXi Biologics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current WuXi Biologics Gross Profit | 4.83 B |
Most of WuXi Biologics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WuXi Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, WuXi Biologics reported 4.83 B of gross profit. This is 115.27% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The gross profit for all United States stocks is 82.36% higher than that of the company.
WuXi Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WuXi Biologics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of WuXi Biologics could also be used in its relative valuation, which is a method of valuing WuXi Biologics by comparing valuation metrics of similar companies.WuXi Biologics is currently under evaluation in gross profit category among related companies.
WuXi Fundamentals
Return On Equity | 0.12 | |||
Return On Asset | 0.0551 | |||
Profit Margin | 0.31 % | |||
Operating Margin | 0.31 % | |||
Current Valuation | 29.3 B | |||
Shares Outstanding | 4.22 B | |||
Shares Owned By Insiders | 14.17 % | |||
Shares Owned By Institutions | 45.95 % | |||
Price To Earning | 107.74 X | |||
Price To Book | 5.92 X | |||
Price To Sales | 2.11 X | |||
Revenue | 10.29 B | |||
Gross Profit | 4.83 B | |||
EBITDA | 4.03 B | |||
Net Income | 3.39 B | |||
Cash And Equivalents | 9.86 B | |||
Cash Per Share | 2.36 X | |||
Total Debt | 640.51 M | |||
Debt To Equity | 0.12 % | |||
Current Ratio | 2.30 X | |||
Book Value Per Share | 8.25 X | |||
Cash Flow From Operations | 3.43 B | |||
Earnings Per Share | 0.14 X | |||
Price To Earnings To Growth | 0.80 X | |||
Number Of Employees | 10.59 K | |||
Beta | 1.09 | |||
Market Capitalization | 34.77 B | |||
Total Asset | 44.03 B | |||
Z Score | 32.4 | |||
Net Asset | 44.03 B |
About WuXi Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WuXi Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WuXi Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WuXi Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
CRM | Salesforce | |
GOOG | Alphabet Inc Class C |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WuXi Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WuXi Biologics information on this page should be used as a complementary analysis to other WuXi Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for WuXi Pink Sheet analysis
When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements |